These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23920356)

  • 1. Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease.
    Iwasaki Y; Kazama JJ; Yamato H; Shimoda H; Fukagawa M
    Bone; 2013 Dec; 57(2):477-83. PubMed ID: 23920356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease.
    Iwasaki Y; Kazama JJ; Yamato H; Fukagawa M
    Bone; 2011 Jun; 48(6):1260-7. PubMed ID: 21397740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered material properties are responsible for bone fragility in rats with chronic kidney injury.
    Iwasaki Y; Kazama JJ; Yamato H; Matsugaki A; Nakano T; Fukagawa M
    Bone; 2015 Dec; 81():247-254. PubMed ID: 26187196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremic Toxicity and Bone in CKD.
    Yamamoto S; Fukagawa M
    J Nephrol; 2017 Oct; 30(5):623-627. PubMed ID: 28573386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential kidney-bone axis involved in the rapid minute-to-minute regulation of plasma Ca2+.
    Nordholm A; Mace ML; Gravesen E; Olgaard K; Lewin E
    BMC Nephrol; 2015 Mar; 16():29. PubMed ID: 25885328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate chronic kidney disease impairs bone quality in C57Bl/6J mice.
    Heveran CM; Ortega AM; Cureton A; Clark R; Livingston EW; Bateman TA; Levi M; King KB; Ferguson VL
    Bone; 2016 May; 86():1-9. PubMed ID: 26860048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.
    Iwasaki-Ishizuka Y; Yamato H; Nii-Kono T; Kurokawa K; Fukagawa M
    Nephrol Dial Transplant; 2005 Sep; 20(9):1904-11. PubMed ID: 15985520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in bone volume and bone resorption by olpadronate treatment in an experimental model of uremic bone disease.
    Tomat A; Gamba CA; Mandalunis P; De Grandi MC; Somoza J; Friedman S; Zeni S
    J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):174-81. PubMed ID: 15951635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiscale effects of the calcimimetic drug, etelcalcetide on bone health of rats with secondary hyperparathyroidism induced by chronic kidney disease.
    Sharma S; Kumar S; Tomar MS; Chauhan D; Kulkarni C; Rajput S; Sadhukhan S; Porwal K; Guha R; Shrivastava A; Gayen JR; Kumar N; Chattopadhyay N
    Bone; 2024 Aug; 185():117126. PubMed ID: 38777312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in skeletal collagen cross-links and matrix hydration in high- and low-turnover chronic kidney disease.
    Allen MR; Newman CL; Chen N; Granke M; Nyman JS; Moe SM
    Osteoporos Int; 2015 Mar; 26(3):977-85. PubMed ID: 25466530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblastic differentiation of bone marrow mesenchymal stem cells in uremic rats.
    Kato T; Mizobuchi M; Sasa K; Yamada A; Ogata H; Honda H; Sakashita A; Kamijo R
    Biochem Biophys Res Commun; 2020 Oct; 532(1):11-18. PubMed ID: 32826057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic toxins adsorbed by AST-120 promote tubular hypertrophy and interstitial fibrosis in nephrectomized rats.
    Okada K; Matsumoto K; Takahashi S
    Kidney Blood Press Res; 2005; 28(1):8-13. PubMed ID: 15377820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
    Niwa T; Ise M
    J Lab Clin Med; 1994 Jul; 124(1):96-104. PubMed ID: 8035108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
    Aoyama I; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Uremic Toxins from the Gut Microbiota on Bone: A Brief Look at Chronic Kidney Disease.
    Black AP; Cardozo LF; Mafra D
    Ther Apher Dial; 2015 Oct; 19(5):436-40. PubMed ID: 25944654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats.
    Nakagawa N; Hasebe N; Sumitomo K; Fujino T; Fukuzawa J; Hirayama T; Kikuchi K
    Am J Nephrol; 2006; 26(5):455-61. PubMed ID: 17057375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beraprost sodium improves survival rates in anti-glomerular basement membrane glomerulonephritis and 5/6 nephrectomized chronic kidney disease rats.
    Yamaguchi S; Inada C; Tamura M; Sato N; Yamada M; Itaba S; Okazaki S; Matsuura H; Fujii S; Matsuda F; Goto Y; Mochizuki H; Kurumatani H; Miyamoto M
    Eur J Pharmacol; 2013 Aug; 714(1-3):325-31. PubMed ID: 23911885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the efficacy of AST-120 (KREMEZIN
    Asai M; Kumakura S; Kikuchi M
    Ren Fail; 2019 Nov; 41(1):47-56. PubMed ID: 30732506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor activator of nuclear factor-kappaB ligand inhibitor osteoprotegerin is a bone-protective agent in a rat model of chronic renal insufficiency and hyperparathyroidism.
    Padagas J; Colloton M; Shalhoub V; Kostenuik P; Morony S; Munyakazi L; Guo M; Gianneschi D; Shatzen E; Geng Z; Tan HL; Dunstan C; Lacey D; Martin D
    Calcif Tissue Int; 2006 Jan; 78(1):35-44. PubMed ID: 16362459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.